Women_s Groups Demand Egg Donation Probe
By The Chosun Ilbo,
The Chosun Ilbo
| 01. 04. 2006
Korea_s already battered biotech industry faces a fresh challenge from women_s rights activists angry at what they see as a high-handed approach to occyte procurement for cloning and other embryonic research. Some 30 women_s rights groups including Korea Women's Associations United (KWAU) on Wednesday urged authorities to investigate egg cell procurement for experiments by the disgraced cloning researcher Hwang Woo-suk. The groups made the call in a press conference at the Seoul Press Center.
The activists said the government was so dazzled by the profits it expected stem cell technology to net the nation that it became blind to the danger to women_s life and health from donating eggs. They said there was an urgent need to discover how many eggs from how many donors were used in Hwang_s experiments, what motivated the donors, how the eggs were extracted, and what institutions were involved. They also called for an investigation of whether two junior researchers in Hwang_s team were pressured to donate their own eggs, and demanded that the government compensate donors for any damage to their health from the...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...